With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and disease resistance.

Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are pattern recognition receptors, which recognize non-self ...

STUTTGART, Germany I June 27, 2025 I La Merie Publishing announced the release of its newest technology market report about gene therapy technologies for in vivo expression of antibodies. The report ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...